HLX15-IV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLX15-IV, covering 2025-03-26 to 2025-03-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination with Lenalidomide-Dexamethasone (Rd) in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma [Phase 3]